Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-2_06-cv-01063/USCOURTS-caed-2_06-cv-01063-1/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1441 Petition for Removal- Product Liability

---

ORDER GRANTING GSK’S EX PARTE APPLICATION TO FILE CERTAIN PAGES OF ITS EXPERT REPORTS UNDER SEAL

- 1 - 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT 

EASTERN DISTRICT OF CALIFORNIA 

SACRAMENTO DIVISION 

TERRI S. O’NEAL, individually and as successorin-interest to the Estate of BENJAMIN L. BRATT; 

BARRY M. BRATT, individually, 

 Plaintiffs, 

 vs. 

SMITHKLINE BEECHAM CORPORATION d/b/a 

GLAXOSMITHKLINE, a Pennsylvania 

Corporation; and DOES 1-50. 

 Defendants. 

Case No.: CV-01063-FCD-DAD 

ORDER GRANTING 

DEFENDANT SMITHKLINE 

BEECHAM CORPORATION d/b/a 

GLAXOSMITHKLINE’s EX PARTE 

APPLICATION TO FILE CERTAIN 

PAGES OF ITS RETAINED 

EXPERTS’ REPORTS UNDER SEAL 

 The Court finds good cause to seal certain pages of Defendant SmithKline Beecham Corporation 

d/b/a GlaxoSmithKline’s (“GSK”) Retained Experts’ Reports, which contain private, confidential 

personal information regarding Plaintiffs and other private individuals, as well as sensitive, confidential 

proprietary information, confidential research, and trade secrets regarding Paxil. Accordingly, the Court 

orders that Dr. Charles Scott’s entire report; pages 14 through 41 of Dr. Jeff Bostic’s report; pages 5 and 

10 of Dr. Judith Jones’s report; and pages 17 through 43 of Dr. Anthony Rothschild’s report shall be 

SEALED. Defendant is ordered to file the reports, excluding the portions as listed above. 

 IT IS SO ORDERED. 

DATED: July 3, 2007 

Case 2:06-cv-01063-FCD-DAD Document 41 Filed 07/03/07 Page 1 of 1